Global Next-Generation Sequencing on Drug Development Market

Report Code: BIO246A

Publish Date: Sep 2023

Publisher: BCC Publishing

Category: Cell Biology

Download Report OverviewTARIFF UPDATE

Limited Period Offer

CUSTOMIZE NOW

Explore Our Services

Already a member? Login to access this report free.

Report Highlights

The global next-generation sequencing (NGS) market in drug development should reach $2.9 billion by 2028 from $1.3 billion in 2023 at a compound annual growth rate (CAGR) of 17.7% for the forecast period of 2023 to 2028.

Report Includes

  • 52 data tables and 39 additional tables
  • An overview of the global markets for next-generation sequencing on drug development
  • Estimation of market size and analyses of global market trends, with data from 2020-2022, estimates for 2023, and projections of compound annual growth rates (CAGRs) through 2028
  • Highlights of the market potential and characterization of next-generation sequencing on drug development market by product, service, end-user type, and region
  • Examination of the key drivers and constraints that will shape the market for next-generation sequencing on drug development and discussion on the upcoming market opportunities and areas of focus to forecast the market into various segments and subsegments
  • Coverage of recent advances, emerging technologies, and developments of the industry
  • Evaluation of key industry acquisitions and strategic alliances and market share analysis of the leading suppliers of the industry
  • Profiles of the key companies of the industry, including 10x Genomics, Bio-Rad Laboratories Inc., Oxford Nanopore Technologies, Qiagen and Takara Bio Inc.

Report Scope

The scope of this report includes NGS technologies, applications, industries, initiatives, patents and companies. The markets for NGS in drug development are given for 2020, 2021, 2022, 2023 and 2028.

This report reviews the NGS technologies and explains why NGS is important in drug development. It then discusses some of the significant research initiatives that impact NGS. The main market-driving forces are also discussed.

This report examines the markets by product type, end user and region. This report provides market data and forecasts for NGS by product type, including instruments, consumables and services for drug development.

Specific geographic markets are discussed, including North America, Europe, Asia-Pacific and the Rest of the World.

BCC Research summarizes the main industry acquisitions and strategic alliances from Jan. 2020, through Dec. 2022, including key alliance trends.

Report Synopsis

Report Metrics Details
Base year considered 2022
Forecast period considered 2023-2028
Base year market size $1.1 billion
Market size forecast $2.9 billion
Growth rate CAGR of 17.7% for the forecast period of 2023-2028
Units considered $ Millions
Segments covered Product Type, End-User, and Region
Regions covered North America, Europe, Asia-Pacific, and Rest of the World (ROW)
Countries covered U.S., Canada, Germany, France, U.K., Italy, Spain, Rest of Europe, China, India, Japan, South Korea, Australia, Rest of Asia-Pacific
Key Market Drivers
  • Increasing R&D Activities using NGS technologies
  • Increase in Healthcare Expenditure
  • Technological Advancements in Sequencing Platforms
  • Shift Towards Precision Medicine
  • Growing demand of NGS for Designing Individualized Medicine to Cancer Patients
  • High Accuracy and Low Cost
Companies studied
10X GENOMICSAGILENT TECHNOLOGIES INC.
BGI (BEIJING GENOMICS INSTITUTE)BIO-RAD LABORATORIES INC.
CD GENOMICSILLUMINA INC.
INTEGRATED DNA TECHNOLOGIES INC.MICRONOMA
NEW ENGLAND BIOLABSOXFORD NANOPORE TECHNOLOGIES PLC.
PACBIOPERKINELMER
PROMEGA CORP.PSOMAGEN INC.
Precision Medicine Group LLC.QIAGEN
F. HOFFMANN-LA ROCHE LTD.THERMO FISHER SCIENTIFIC INC.
TAKARA BIO INC.TECAN TRADING AG
Need pricing for multiple titles, a complete report bundle, or something specially curated to fit your budget? EXPLORE OFFERS

Frequently Asked Questions (FAQs)

The next-generation sequencing on drug development market is projected to grow from $1.1 billion in 2022 to $2.9 billion in 2028 at a compound annual growth rate (CAGR) of 17.7% during the forecast period.
The key factors driving the growth of the next-generation sequencing on drug development market include increasing research and development activities utilizing NGS technologies, the rise in technological advancements, the shift towards precision medicine, and the Growing demand to NGS for designing individualized medicine for cancer patients is boosting the growth of the next-generation sequencing on the drug development market.
The next-generation sequencing on the drug development market is segmented based on product type, by end-user, and by region.
The consumables segment will dominate the next-generation sequencing on drug development market by the end of 2028.
Key companies in the market include Illumina, Inc., Thermo Fisher Scientific Inc., Agilent Technologies, Inc., QIAGEN, Oxford Nanopore Technologies plc., F Hoffmann-La Roche AG, Takara Bio, PacBio., Tecan Group, 10X Genomics, Bio-Rad Laboratories, Inc., PerkinElmer, BGI Genomics, Psomagen, Inc., Integrated DNA technologies, CD Genomics, New England Biolabs, and Promega Corp.

Analyst Credentials

BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.

Let us assist you! Our analysts are ready to tailor this report to your specific need. Talk to Our Analyst

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesMember Price
Full Report: Global Next-Generation Sequencing on Drug Development Market177Free
Chapter- 1: Introduction5Free
Chapter- 2: Summary and Highlights5Free
Chapter- 3: Market Overview33Free
Chapter- 4: Market Dynamics8Free
Chapter- 5: NGS in Drug Development by Product Type8Free
Chapter- 6: NGS Market in Drug Development by End User4Free
Chapter- 7: NGS Market in Drug Development by Region11Free
Chapter- 8: Sustainability of NGS in Drug Development: An ESG Perspective10Free
Chapter- 9: Emerging Technologies and Developments3Free
Chapter- 10: Patent Analysis15Free
Chapter- 11: M&A and Funding Outlook3Free
Chapter- 12: Competitive Landscape3Free
Chapter- 13: Company Profiles68Free
Chapter- 14: Appendix: Acronyms1Free

Related Reports

2024 Cell and Gene: Research Review

Published - Apr 2025 | Publisher - Various Analysts | Code - BIO267A

Research Reviews from BCC Research provide market professionals with concise market coverage within a specific research category. These Research Reviews include portions of several market research reports that were published in 2024.

2024 DNA and RNA Synthesis Research Review

Published - Mar 2025 | Publisher - Various Analysts | Code - BIO265A

The Cell Biology industry is a multi-billion-dollar industry whose outlook is supposed to rise in the coming years. This report provides a sampling of the types of quantitative market information, analysis and guidance that has been aiding business decision making since the inception of BCC Research in 1971.

Global DNA Sequencing: Research, Applied and Clinical Markets

Published - Dec 2024 | Publisher - BCC Publishing | Code - BIO045J

The global market for DNA sequencing is expected to grow from $14.8 billion in 2024 and is projected to reach $34.8 billion by the end of 2029, at a compound annual growth rate (CAGR) of 18.6% during the forecast period of 2024 to 2029.

Breakthrough Therapies: Market Dynamics and Investment Opportunities

Published - Dec 2024 | Publisher - BCC Publishing | Code - PHM176B

The global market for breakthrough therapy drugs was valued at $133.3 billion in 2023. This market is expected to grow from $150.6 billion in 2024 to $287.5 billion by 2029, at a compound annual growth rate (CAGR) of 13.8% from 2024 to 2029.

Recent Reports

Proteomics: Technologies and Global Markets

Published - May 2025 | Publisher - BCC Publishing | Code - BIO034G

The global market for proteomic technologies was valued at $27.6 billion in 2024. It is projected to grow from $31.0 billion in 2025 to $57.2 billion by the end of 2030, at a compound annual growth rate (CAGR) of 13.0% from 2025 to 2030.

Biologic Therapeutic Drugs: Technologies and Global Markets

Published - May 2025 | Publisher - BCC Publishing | Code - BIO079F

The global market for biologic therapeutic drugs is estimated to increase from $499.2 billion in 2024 to reach $794.5 billion by 2029, at a compound annual growth rate (CAGR) of 9.7% from 2024 through 2029.

Global Markets and Manufacturing Technologies for Protein Drugs

Published - Apr 2025 | Publisher - BCC Publishing | Code - BIO021G

The global protein drugs market is expected to grow from $441.7 billion in 2024 and is projected to reach $655.7 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.2% during the forecast period of 2024 to 2029.

G-Protein Coupled Receptor (GPCR) Targeting: Technologies and Global Markets

Published - Apr 2025 | Publisher - BCC Publishing | Code - BIO136B

The global G protein-coupled receptor (GPCR) market is expected to grow from $4.4 billion in 2024 and is projected to reach $6.1 billion by the end of 2029, at a compound annual growth rate (CAGR) of 6.8% during the forecast period of 2024 to 2029.

2024 Cell and Gene: Research Review

Published - Apr 2025 | Publisher - Various Analysts | Code - BIO267A

Research Reviews from BCC Research provide market professionals with concise market coverage within a specific research category. These Research Reviews include portions of several market research reports that were published in 2024.

Top Trending Reports

Global Markets for Emerging Medical Device Technologies

Published - Mar 2025 | Publisher - BCC Publishing | Code - HLC191C

The global market for emerging medical devices is estimated to increase from $136.6 billion in 2024 to reach $223.9 billion by 2029, at a compound annual growth rate (CAGR) of 10.4% from 2024 through 2029.

Global Diabetic Care Devices Market

Published - Feb 2025 | Publisher - BCC Publishing | Code - MDS019B

The global market for diabetes monitoring devices is expected to grow from $16.6 billion in 2024 to $26.8 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.1% from 2024 through 2029.

Single-Cell Genomics and Proteomics: Emerging Technologies and Markets

Published - Apr 2025 | Publisher - BCC Publishing | Code - BIO143C

The global market for single-cell genomics and proteomics is expected to grow from $4.0 billion in 2024 to reach $9.1 billion by the end of 2029, at a compound annual growth rate (CAGR) of 17.6% from 2024 through 2029.

Global Lithium-ion Battery Market

Published - Mar 2025 | Publisher - BCC Publishing | Code - FCB067A

The global market for lithium-ion battery (LIB) is expected to grow from $117.8 billion in 2024 and is projected to reach $221.7 billion by the end of 2029, at a compound annual growth rate (CAGR) of 13.5% during the forecast period of 2024 to 2029.

2024 Medical Devices Research Review

Published - Mar 2025 | Publisher - BCC Publishing | Code - MDS060B

The medical device industry is a multi-billion-dollar industry whose outlook is supposed to rise in the coming years These devices treat and diagnose a multitude of patient conditions and work much better than drugs.

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More
Global Next-Generation Sequencing on Drug Development Market
Sample Report